PATENT CLAIM ANALYSIS

Application Number: 16052724
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-06
Patent Classification: ["514", "549000"]

Abstract:
In various embodiments, the present invention provides methods of treating and/or preventing pediatric metabolic syndrome comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.

Claim (Index 20):
The method of  claim 19  wherein the subject exhibits one or more of: (a) a reduction in triglyceride level of at least about 5% as compared to baseline; (b) a less than 30% increase in non-HDL-C levels or a reduction in non-HDL-C levels of at least about 1% as compared to baseline; (c) an increase in HDL-C levels of at least about 5% as compared to baseline; and/or (d) a less than 60% increase in LDL-C levels compared to baseline.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 96.0
- Lexical Diversity: 1.12903
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13282145', '13711329', '13349157', '13349153', '13711324']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7188926361361782
- 35 USC 102 Novelty (BERT): 0.5250282529849405
- Combined Prediction Score: 0.6995061978210544
- Mean Citation Score: 291.38515399999994
- Max Citation Score: 292.50858
- Similarity Product: 188.3175701988781

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test